Consolidated Statements Of Cash Flows - USD ($) $ in Thousands	2 Months Ended	7 Months Ended	9 Months Ended
	Sep. 30, 2015	Aug. 14, 2015	Sep. 30, 2014
Adjustments to reconcile net loss to cash provided by operations:
Inventory write-downs	$ 30,900
Cash flow from financing activities:
Cash and cash equivalents at beginning of period		$ 17,550
Cash and cash equivalents at end of period	13,461
Predecessor
Cash flow from operating activities:
Net loss		(120,649)	$ (201,893)
Adjustments to reconcile net loss to cash provided by operations:
Depreciation and amortization		45,461	93,123
Impairments		35,381	121,570
Inventory write-downs		0	18,800
Deferred income tax provision		924	(4,943)
Post-retirement and pension plan changes		2,998	4,097
Stock-based compensation		15,357	4,009
Interest expense		14,180	11,105
Other charges, net		102	4,047
Increase (decrease) in working capital		45,594	48,577
Increase in long-term assets and liabilities		(11,025)	(15,603)
Net cash provided by operating activities		28,323	82,889
Cash flow from investing activities:
Capital expenditures		(32,301)	(69,314)
Proceeds from the sale of assets		646	4,079
Proceeds from derivative instruments		(8,263)	(573)
Insurance recoveries		0	2,834
Net cash used in investing activities		(39,918)	(62,974)
Cash flow from financing activities:
Short-term debt, net		18,511	(17)
Revolving Facility borrowings		160,000	229,000
Revolving Facility reductions		(99,000)	(240,000)
Repayment of Senior Subordinated Notes		(200,000)	0
Issuance of Preferred Shares		150,000	0
Principal payments on long-term debt		(89)	(158)
Supply chain financing		0	(9,455)
Proceeds from exercise of stock options		32	2,813
Purchase of treasury shares		(63)	(620)
Revolving Facility refinancing fees		(5,068)	(2,741)
Other		(3,499)	1,011
Net cash (used in) provided by financing activities		20,824	(20,167)
Net increase (decrease) in cash and cash equivalents		9,229	(252)
Effect of exchange rate changes on cash and cash equivalents		(1,746)	(758)
Cash and cash equivalents at beginning of period	25,033	17,550	11,888
Cash and cash equivalents at end of period		25,033	10,878
Change in current assets:
Accounts and notes receivable, net		61,008	29,693
Inventories		1,164	46,424
Prepaid expenses and other current assets		2,551	(15,560)
Decrease in accounts payable and accruals		(18,728)	(11,072)
Rationalizations		(2,677)	(5,671)
Increase in interest payable		2,276	4,763
Change in working capital		45,594	$ 48,577
Successor
Cash flow from operating activities:
Net loss	(7,303)
Adjustments to reconcile net loss to cash provided by operations:
Depreciation and amortization	10,604
Impairments	0
Deferred income tax provision	863
Post-retirement and pension plan changes	486
Stock-based compensation	0
Interest expense	786
Other charges, net	(492)
Increase (decrease) in working capital	(47)
Increase in long-term assets and liabilities	(985)
Net cash provided by operating activities	3,912
Cash flow from investing activities:
Capital expenditures	(5,239)
Proceeds from the sale of assets	542
Proceeds from derivative instruments	84
Insurance recoveries	0
Net cash used in investing activities	(4,613)
Cash flow from financing activities:
Short-term debt, net	(10,180)
Revolving Facility borrowings	22,000
Revolving Facility reductions	(21,000)
Repayment of Senior Subordinated Notes	0
Issuance of Preferred Shares	0
Principal payments on long-term debt	(12)
Supply chain financing	0
Proceeds from exercise of stock options	0
Purchase of treasury shares	0
Revolving Facility refinancing fees	0
Other	(1,385)
Net cash (used in) provided by financing activities	(10,577)
Net increase (decrease) in cash and cash equivalents	(11,278)
Effect of exchange rate changes on cash and cash equivalents	(294)
Cash and cash equivalents at beginning of period	25,033
Cash and cash equivalents at end of period	13,461	$ 25,033
Change in current assets:
Accounts and notes receivable, net	(16,927)
Inventories	18,436
Prepaid expenses and other current assets	3,375
Decrease in accounts payable and accruals	(5,822)
Rationalizations	(1,642)
Increase in interest payable	2,533
Change in working capital	$ (47)